Humira 40 mg / 0.4 ml (Adalimumab 40 mg / 0.4 ml) by AbbVie.
Indications: Rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa and uveitis.
Administration: Subcutaneous injection, typically 40 mg every other week.
Storage: Store in a refrigerator at 2–8 °C. Do not freeze. Keep in the outer carton to protect from light. May be stored up to 25 °C for 14 days.
Prescription-only medicine (POM). Supplied against a valid prescription / to licensed healthcare professionals only.
| Manufacturer | AbbVie |
| Active ingredient | Adalimumab 40 mg / 0.4 ml (citrate-free, 100 mg/ml) — anti-TNF-α monoclonal antibody. |
| Strength & pack | 2 pre-filled pens or syringes. |
| Form | Solution for injection |
| Storage | Store in a refrigerator at 2–8 °C. Do not freeze. Keep in the outer carton to protect from light. May be stored up to 25 °C for 14 days. |
| Regulatory status | Prescription-only medicine (POM). Supplied against a valid prescription / to licensed healthcare professionals only. |